Pharmacological chaperone treatment with Cystadane in aspartylglucosaminuria: an open-label, phase Ib/II trial
Here, this phase Ib/II interventional clinical trial shows that betaine/Cystadane is safe to use and significantly reduces urinary accumulation of glycoasparagines and increases aspartylglucosaminidase activity in aspartylglucosaminuria.